Background The bariatric surgical population is a particularly high risk population for VTE. It
is unclear if standard (ie non-adjusted) thromboprophylaxis doses of low-molecular weight …

Introduction: Rates of obesity have been increasing worldwide and with the current situation
obesity now represents an epidemic. Bariatric surgery is one the most effective ways to help …

Background Venous thromboembolism (VTE) is a leading cause of death in obese patients
undergoing bariatric surgery (BS), but there is neither consensus nor high-level guidelines …

Background: Obesity is considered a highly prevalent risk factor for venous
thromboembolism (VTE) in hospitalized patients. However, recommendations for VTE …

Background Evidence-based data on optimal approach for prophylaxis of deep venous
thrombosis (VTE) and pulmonary embolism (PE) in bariatric operations is discussed. Using …

Objective To evaluate the effectiveness and safety of 3 predominant venous
thromboembolism (VTE) prophylaxis strategies among patients undergoing bariatric …

Background The optimal dose of low molecular weight heparin (LMWH) to prevent venous
thromboembolism (VTE) after bariatric surgery remains controversial. The aim of this …

Bariatric surgical procedures are now a common method of obesity treatment with
established effectiveness. Venous thromboembolism (VTE) events, which include deep vein …

Introduction Enoxaparin is administered for venous thromboembolic (VTE) prophylaxis in
bariatric surgery patients. There is concern whether body mass index (BMI)-based …

Background There are limited data on appropriate dosing of low-molecular-weight heparins
(LMWHs) for venous thromboembolism (VTE) prophylaxis in bariatric surgery. The primary …